Fountainhead AM’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-142,143
Closed -$2.1M 171
2025
Q3
$2.1M Buy
142,143
+53,787
+61% +$805K 0.28% 48
2025
Q2
$1.34M Buy
88,356
+31,823
+56% +$465K 0.19% 55
2025
Q1
$814K Buy
56,533
+3,322
+6% +$50.8K 0.13% 60
2024
Q4
$806K Sell
53,211
-359
-0.7% -$5.77K 0.15% 57
2024
Q3
$881K Buy
53,570
+1,095
+2% +$17.9K 0.19% 48
2024
Q2
$861K Buy
52,475
+4,905
+10% +$78.9K 0.2% 47
2024
Q1
$793K Buy
47,570
+921
+2% +$14.3K 0.19% 53
2023
Q4
$697K Buy
46,649
+13,766
+42% +$200K 0.19% 52
2023
Q3
$476K Buy
+32,883
New +$492K 0.17% 49

Other funds holding BCAT

Fountainhead AM's BCAT Position: Q4 2025 in Review

Fountainhead AM sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q4 2025, closing a stake of 142,143 shares — an estimated $2.1M sold.

Fountainhead AM first reported a position in BCAT in Q3 2023 and held it in 9 quarters. The position peaked at $2.1M in Q3 2025. 106 funds tracked by Wall St. Rank hold BCAT as of Q4 2025.

  • Fountainhead AM reported no remaining BlackRock Capital Allocation Term Trust position as of Q4 2025 after selling out during the quarter.
  • Fountainhead AM sold 142,143 BlackRock Capital Allocation Term Trust shares in Q4 2025, an estimated $2.1M.
  • Fountainhead AM first reported a position in BlackRock Capital Allocation Term Trust in Q3 2023 and held it in 9 quarters.
  • Fountainhead AM's BlackRock Capital Allocation Term Trust position peaked at $2.1M in Q3 2025.
  • 106 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q4 2025.

Based on Fountainhead AM's 13F filing for Q4 2025, filed 18 Feb 2026.